Alzheimer's & Dementia·27 AugMMSE-CDR-SB residual as an exploratory indicator of deviation from an Alzheimer's disease-typical cognitive-functional patternStudy in peopleBiomarkersPaper
medRxiv·20 AugComparator supplement patterns qualify the clinical interpretation of an EHR-derived glucosamine signal in Alzheimer's diseasePreprint: study in peoplePopulationsPaper
medRxiv·20 AugBiomarker-Informed Interpretation of Dyadic Cognitive Function Index Scores in Cognitively Unimpaired Older AdultsPreprint: cross-sectional study of 1,682 peopleBiomarkersPaper
AAIC 2025 Abstract·25 DecTasks discriminating cognitive impairment levels: Item Response Theory applied to the Alzheimer's Disease Assessment Scale Cognitive SubscaleTrial in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecAlterations in the blood‐based biomarker testing performances following correction for renal functionStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·24 DecPlasma p ‐Tau217 assay performance in Japan: from preclinical/prodromal cohort to DMT registryStudy in peopleBiomarkersPaper
AAIC 2025 Abstract·23 DecTherapeutic Time Window of Disease‐Modifying Therapy for Early Alzheimer's DiseaseStudy in peoplePopulationsPaper